You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 296 No. 16, October 25, 2006 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Letters
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on ISI (1)
 •Contact me when this article is cited
 Related Content
 •Related articles
 •Similar articles in JAMA
 Topic Collections
 •Cardiovascular Disease/ Myocardial Infarction
 •Alert me on articles by topic

Granulocyte Colony-Stimulating Factor and Acute Myocardial Infarction

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

To the Editor: The clinical trial of G-CSF therapy for patients with AMI by Dr Zohlnhöfer and colleagues1 showed that when compared with placebo, the therapy had no benefit in terms of infarct size and left ventricular function. Another trial also failed to show any functional improvement after AMI with G-CSF treatment.2 These results suggest that there might be some unknown mechanisms undermining the therapy.

A recent basic research study might provide an explanation for these results. Katayama et al3 found evidence that the sympathetic nervous system regulates hematopoietic stem cell mobilization in bone marrow. In their experiments, G-CSF–induced stem cell mobilization was stimulated by beta2-adrenergic agonists but was suppressed by beta-blockers. These findings suggest that beta-blockers might have attenuated the effect of G-CSF in the patients studied by Zohlnhöfer et al by affecting the stem cell mobilization process. The authors reported that 100% of patients in the G-CSF group . . . [Full Text of this Article]

Jaewon Oh
drjaewonoh@gmail.com
Yonsei University College of Medicine
Seoul, Korea

Dae Hyun Kim, MD, MPH
Jefferson Medical College
Philadelphia, Pa

Hyunseok Kang, MD
Yonsei University Graduate School of Public Health
Seoul, Korea


RELATED ARTICLES

Granulocyte Colony-Stimulating Factor and Acute Myocardial Infarction
Wolf-Rüdiger Schäbitz, Sigrid Nikol, and Armin Schneider
JAMA. 2006;296(16):1967-1968.
EXTRACT | FULL TEXT  

Granulocyte Colony-Stimulating Factor and Acute Myocardial Infarction—Reply
Dietlind Zohlnhöfer, Ilka Ott, Adnan Kastrati, and Albert Schömig
JAMA. 2006;296(16):1968-1969.
EXTRACT | FULL TEXT  

Stem Cell Mobilization by Granulocyte Colony-Stimulating Factor in Patients With Acute Myocardial Infarction: A Randomized Controlled Trial
Dietlind Zohlnhöfer, Ilka Ott, Julinda Mehilli, Kathrin Schömig, Fabian Michalk, Tareq Ibrahim, Günther Meisetschläger, Jasper von Wedel, Hildegard Bollwein, Melchior Seyfarth, Josef Dirschinger, Claus Schmitt, Markus Schwaiger, Adnan Kastrati, Albert Schömig, and for the REVIVAL-2 Investigators
JAMA. 2006;295(9):1003-1010.
ABSTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2006 American Medical Association. All Rights Reserved.